{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:21:40Z","timestamp":1779128500221,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100014355","name":"Nirma University","doi-asserted-by":"publisher","award":["NU\/Ph.D.\/Major_Res_Pro\/IP-NU\/21-22\/1115"],"award-info":[{"award-number":["NU\/Ph.D.\/Major_Res_Pro\/IP-NU\/21-22\/1115"]}],"id":[{"id":"10.13039\/501100014355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"DOI":"10.1007\/s13721-025-00511-7","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:44:35Z","timestamp":1742377475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Structure-guided computational design of novel polycyclic aromatic compounds as telomerase inhibitors for the treatment of cancer"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8977-2071","authenticated-orcid":false,"given":"Rajdeep","family":"Dey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1474-425X","authenticated-orcid":false,"given":"Bhumika","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-0647","authenticated-orcid":false,"given":"Vivek Kumar","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-0488","authenticated-orcid":false,"given":"Nandan","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-1322","authenticated-orcid":false,"given":"Saumya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6431-0695","authenticated-orcid":false,"given":"Hardik","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"511_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/157489212798357958","volume":"7","author":"A Agrawal","year":"2012","unstructured":"Agrawal A, Dang S, Gabrani R (2012) Recent patents on Anti-Telomerase Cancer therapy. PRA 7:102\u2013117. https:\/\/doi.org\/10.2174\/157489212798357958","journal-title":"PRA"},{"key":"511_CR2","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s00018-016-2146-9","volume":"73","author":"SC Akincilar","year":"2016","unstructured":"Akincilar SC, Unal B, Tergaonkar V (2016) Reactivation of telomerase in cancer. Cell Mol Life Sci 73:1659\u20131670. https:\/\/doi.org\/10.1007\/s00018-016-2146-9","journal-title":"Cell Mol Life Sci"},{"key":"511_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nsmb.3092","volume":"22","author":"N Arnoult","year":"2015","unstructured":"Arnoult N, Karlseder J (2015) Complex interactions between the DNA-damage response and mammalian telomeres. Nat Struct Mol Biol 22:859\u2013866. https:\/\/doi.org\/10.1038\/nsmb.3092","journal-title":"Nat Struct Mol Biol"},{"key":"511_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.18632\/genesandcancer.140","volume":"8","author":"T Augustine","year":"2017","unstructured":"Augustine T, Maitra R, Goel S (2017) Telomere length regulation through epidermal growth factor receptor signaling in cancer. Genes Cancer 8:550\u2013558. https:\/\/doi.org\/10.18632\/genesandcancer.140","journal-title":"Genes Cancer"},{"key":"511_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"511_CR5","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1182\/blood-2015-08-667485","volume":"127","author":"C B\u00e4r","year":"2016","unstructured":"B\u00e4r C, Povedano JM, Serrano R et al (2016) Telomerase gene therapy rescues telomere length, bone marrow Aplasia, and survival in mice with aplastic anemia. Blood 127:1770\u20131779. https:\/\/doi.org\/10.1182\/blood-2015-08-667485","journal-title":"Blood"},{"key":"511_CR7","doi-asserted-by":"publisher","first-page":"2200010","DOI":"10.1002\/anbr.202200010","volume":"2","author":"V Chandrasekar","year":"2022","unstructured":"Chandrasekar V, Singh AV, Maharjan RS et al (2022) Perspectives on the technological aspects and biomedical applications of Virus-Like particles\/nanoparticles in reproductive biology: insights on the medicinal and toxicological outlook. Adv NanoBiomed Res 2:2200010. https:\/\/doi.org\/10.1002\/anbr.202200010","journal-title":"Adv NanoBiomed Res"},{"key":"511_CR8","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.4155\/fmc-2022-0204","volume":"14","author":"U Chaube","year":"2022","unstructured":"Chaube U, Dey R, Shaw S et al (2022) Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer. Future Med Chem 14:1789\u20131809. https:\/\/doi.org\/10.4155\/fmc-2022-0204","journal-title":"Future Med Chem"},{"key":"511_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, Chehelgerdi M, Allela OQB et al (2023) Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer 22:169. https:\/\/doi.org\/10.1186\/s12943-023-01865-0","journal-title":"Mol Cancer"},{"key":"511_CR10","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1080\/14756366.2018.1484735","volume":"33","author":"X Chen","year":"2018","unstructured":"Chen X, Zha G-F, Wang JQ, Liu X-H (2018) Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro. J Enzyme Inhib Med Chem 33:1266\u20131270. https:\/\/doi.org\/10.1080\/14756366.2018.1484735","journal-title":"J Enzyme Inhib Med Chem"},{"key":"511_CR11","doi-asserted-by":"publisher","first-page":"205031212110343","DOI":"10.1177\/20503121211034366","volume":"9","author":"DT Debela","year":"2021","unstructured":"Debela DT, Muzazu SG, Heraro KD et al (2021) New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med 9:20503121211034366. https:\/\/doi.org\/10.1177\/20503121211034366","journal-title":"SAGE Open Med"},{"key":"511_CR12","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","volume":"68","author":"VT DeVita","year":"2008","unstructured":"DeVita VT, Chu E (2008) A history of Cancer chemotherapy. Cancer Res 68:8643\u20138653. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-6611","journal-title":"Cancer Res"},{"key":"511_CR13","doi-asserted-by":"crossref","unstructured":"Dey R, Chaube U, Bhatt H, Patel B (2024a) Small molecule drug design. Reference module in life sciences. Elsevier, p B9780323955027002621","DOI":"10.1016\/B978-0-323-95502-7.00262-1"},{"key":"511_CR14","doi-asserted-by":"publisher","first-page":"139330","DOI":"10.1016\/j.molstruc.2024.139330","volume":"1318","author":"R Dey","year":"2024","unstructured":"Dey R, Shaw S, Bhatt H et al (2024b) Synthesis, biological screening, and binding mode analysis of some N-substituted tetrahydroquinoline analogs as apoptosis inducers and anticancer agents. J Mol Struct 1318:139330. https:\/\/doi.org\/10.1016\/j.molstruc.2024.139330","journal-title":"J Mol Struct"},{"key":"511_CR15","doi-asserted-by":"publisher","first-page":"e202404444","DOI":"10.1002\/slct.202404444","volume":"9","author":"R Dey","year":"2024","unstructured":"Dey R, Vishwakarma K, Patel B et al (2024c) Evolution of telomerase inhibitors: A review on key patents from 2015 to 2023. ChemistrySelect 9:e202404444. https:\/\/doi.org\/10.1002\/slct.202404444","journal-title":"ChemistrySelect"},{"key":"511_CR16","doi-asserted-by":"publisher","first-page":"111634","DOI":"10.1016\/j.biopha.2021.111634","volume":"139","author":"PA Dhage","year":"2021","unstructured":"Dhage PA, Sharbidre AA, Dakua SP, Balakrishnan S (2021) Leveraging hallmark Alzheimer\u2019s molecular targets using phytoconstituents: current perspective and emerging trends. Biomed Pharmacother 139:111634. https:\/\/doi.org\/10.1016\/j.biopha.2021.111634","journal-title":"Biomed Pharmacother"},{"key":"511_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Knoll EH et al (2006) PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des 20:647\u2013671. https:\/\/doi.org\/10.1007\/s10822-006-9087-6","journal-title":"J Comput Aided Mol Des"},{"key":"511_CR18","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1021\/jm801245v","volume":"51","author":"WC Drewe","year":"2008","unstructured":"Drewe WC, Nanjunda R, Gunaratnam M et al (2008) Rational design of substituted diarylureas: A scaffold for binding to G-Quadruplex motifs. J Med Chem 51:7751\u20137767. https:\/\/doi.org\/10.1021\/jm801245v","journal-title":"J Med Chem"},{"key":"511_CR19","first-page":"11","volume":"110","author":"JC Eissenberg","year":"2013","unstructured":"Eissenberg JC (2013) Telomeres, cancer & aging: live long &. prosper? Mo Med 110:11\u201316","journal-title":"prosper? Mo Med"},{"key":"511_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11548-020-02120-3","volume":"15","author":"SS Esfahani","year":"2020","unstructured":"Esfahani SS, Zhai X, Chen M et al (2020) Lattice-Boltzmann interactive blood flow simulation pipeline. Int J CARS 15:629\u2013639. https:\/\/doi.org\/10.1007\/s11548-020-02120-3","journal-title":"Int J CARS"},{"key":"511_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/cells8050392","volume":"8","author":"J Hong","year":"2019","unstructured":"Hong J, Yun C-O (2019) Telomere gene therapy: polarizing therapeutic goals for treatment of various diseases. Cells 8:392. https:\/\/doi.org\/10.3390\/cells8050392","journal-title":"Cells"},{"key":"511_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","volume":"8","author":"MA Jafri","year":"2016","unstructured":"Jafri MA, Ansari SA, Alqahtani MH, Shay JW (2016) Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med 8:69. https:\/\/doi.org\/10.1186\/s13073-016-0324-x","journal-title":"Genome Med"},{"key":"511_CR23","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1016\/j.arabjc.2016.11.004","volume":"12","author":"MF Khan","year":"2019","unstructured":"Khan MF, Verma G, Akhtar W et al (2019) Pharmacophore modeling, 3D-QSAR, Docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and sulfonamides as antitubulin agents. Arab J Chem 12:5000\u20135018. https:\/\/doi.org\/10.1016\/j.arabjc.2016.11.004","journal-title":"Arab J Chem"},{"key":"511_CR24","doi-asserted-by":"publisher","first-page":"104077","DOI":"10.1016\/j.bioorg.2020.104077","volume":"102","author":"C Liu","year":"2020","unstructured":"Liu C, Zhou H, Sheng XB et al (2020) Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532. Bioorg Chem 102:104077. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104077","journal-title":"Bioorg Chem"},{"key":"511_CR25","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1080\/14756366.2018.1564046","volume":"34","author":"M Maher","year":"2019","unstructured":"Maher M, Kassab AE, Zaher AF, Mahmoud Z (2019) Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR\/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis. J Enzyme Inhib Med Chem 34:532\u2013546. https:\/\/doi.org\/10.1080\/14756366.2018.1564046","journal-title":"J Enzyme Inhib Med Chem"},{"key":"511_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1874844901805010012","volume":"5","author":"SN Mali","year":"2018","unstructured":"Mali SN, Chaudhari HK (2018) Computational studies on Imidazo[1,2-a] Pyridine-3-Carboxamide analogues as antimycobacterial agents: common pharmacophore generation, Atom-based 3D-QSAR, molecular dynamics simulation, QikProp, molecular Docking and prime MMGBSA approaches. PHARMSCI 5:12\u201323. https:\/\/doi.org\/10.2174\/1874844901805010012","journal-title":"PHARMSCI"},{"key":"511_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13321-024-00814-3","volume":"16","author":"K Mansouri","year":"2024","unstructured":"Mansouri K, Moreira-Filho JT, Lowe CN et al (2024) Free and open-source QSAR-ready workflow for automated standardization of chemical structures in support of QSAR modeling. J Cheminform 16:19. https:\/\/doi.org\/10.1186\/s13321-024-00814-3","journal-title":"J Cheminform"},{"key":"511_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10522-024-10098-7","volume":"25","author":"CE Mason","year":"2024","unstructured":"Mason CE, Sierra MA, Feng HJ, Bailey SM (2024) Telomeres and aging: on and off the planet! Biogerontology 25:313\u2013327. https:\/\/doi.org\/10.1007\/s10522-024-10098-7","journal-title":"Biogerontology"},{"key":"511_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2174\/138955712802762220","volume":"12","author":"Y Mizushina","year":"2012","unstructured":"Mizushina Y, Takeuchi T, Sugawara F, Yoshida H (2012) Anti-cancer targeting telomerase inhibitors: \u03b2-rubromycin and oleic acid. Mini Rev Med Chem 12:1135\u20131143. https:\/\/doi.org\/10.2174\/138955712802762220","journal-title":"Mini Rev Med Chem"},{"key":"511_CR30","doi-asserted-by":"publisher","first-page":"e202300328","DOI":"10.1002\/cmdc.202300328","volume":"18","author":"NS Mone","year":"2023","unstructured":"Mone NS, Syed S, Ravichandiran P et al (2023) Synergistic and additive effects of menadione in combination with antibiotics on Multidrug-Resistant Staphylococcus aureus: insights from Structure\u2010Function. Anal Naphthoquinones ChemMedChem 18:e202300328. https:\/\/doi.org\/10.1002\/cmdc.202300328","journal-title":"Anal Naphthoquinones ChemMedChem"},{"key":"511_CR31","first-page":"4004","volume":"59","author":"I Naasani","year":"1999","unstructured":"Naasani I, Seimiya H, Yamori T, Tsuruo T (1999) FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Res 59:4004\u20134011","journal-title":"Cancer Res"},{"key":"511_CR32","doi-asserted-by":"publisher","first-page":"33171","DOI":"10.1074\/jbc.M113.518175","volume":"288","author":"M Nakashima","year":"2013","unstructured":"Nakashima M, Nandakumar J, Sullivan KD et al (2013) Inhibition of telomerase recruitment and Cancer cell death. J Biol Chem 288:33171\u201333180. https:\/\/doi.org\/10.1074\/jbc.M113.518175","journal-title":"J Biol Chem"},{"key":"511_CR53","doi-asserted-by":"publisher","unstructured":"Papaleo E, Mereghetti P, Fantucci P et al (2009) Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case. J Mol Graph Model 27:889\u2013899. https:\/\/doi.org\/10.1016\/j.jmgm.2009.01.006","DOI":"10.1016\/j.jmgm.2009.01.006"},{"key":"511_CR33","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/labinvest.3700352","volume":"85","author":"K Piotrowska","year":"2005","unstructured":"Piotrowska K, Kleideiter E, M\u00fcrdter TE et al (2005) Optimization of the TRAP assay to evaluate specificity of telomerase inhibitors. Lab Invest 85:1565\u20131569. https:\/\/doi.org\/10.1038\/labinvest.3700352","journal-title":"Lab Invest"},{"key":"511_CR34","first-page":"657","volume":"1","author":"H Seimiya","year":"2002","unstructured":"Seimiya H, Oh-hara T, Suzuki T et al (2002) Telomere shortening and growth Inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991. Mol Cancer Ther 1:657\u2013665","journal-title":"Mol Cancer Ther"},{"key":"511_CR35","doi-asserted-by":"publisher","first-page":"e202303291","DOI":"10.1002\/slct.202303291","volume":"9","author":"S Shaw","year":"2024","unstructured":"Shaw S, Dey R, Bhatt H et al (2024) Designing of target-specific N \u2010substituted tetrahydroquinoline derivatives as potent mTOR inhibitors via integrated structure\u2010guided computational approaches. ChemistrySelect 9:e202303291. https:\/\/doi.org\/10.1002\/slct.202303291","journal-title":"ChemistrySelect"},{"key":"511_CR36","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1021\/acs.jcim.5b00336","volume":"55","author":"F Shirgahi Talari","year":"2015","unstructured":"Shirgahi Talari F, Bagherzadeh K, Golestanian S et al (2015) Potent human telomerase inhibitors: molecular dynamic simulations, multiple Pharmacophore-Based virtual screening, and biochemical assays. J Chem Inf Model 55:2596\u20132610. https:\/\/doi.org\/10.1021\/acs.jcim.5b00336","journal-title":"J Chem Inf Model"},{"key":"511_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00018-019-03369-x","volume":"77","author":"EM Smith","year":"2020","unstructured":"Smith EM, Pendlebury DF, Nandakumar J (2020) Structural biology of telomeres and telomerase. Cell Mol Life Sci 77:61\u201379. https:\/\/doi.org\/10.1007\/s00018-019-03369-x","journal-title":"Cell Mol Life Sci"},{"key":"511_CR38","doi-asserted-by":"publisher","unstructured":"Thaker A, Patel S, Dey R et al (2024) Advancements in mTOR inhibitors for Non-Small cell lung cancer: mechanisms, efficacy, and future perspectives. https:\/\/doi.org\/10.1055\/a-2507-3598. Synlett a-2507-3598","DOI":"10.1055\/a-2507-3598"},{"key":"511_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-023-00832-0","volume":"23","author":"A Tropsha","year":"2024","unstructured":"Tropsha A, Isayev O, Varnek A et al (2024) Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR. Nat Rev Drug Discov 23:141\u2013155. https:\/\/doi.org\/10.1038\/s41573-023-00832-0","journal-title":"Nat Rev Drug Discov"},{"key":"511_CR40","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s11224-020-01503-1","volume":"31","author":"BD Varpe","year":"2020","unstructured":"Varpe BD, Jadhav SB, Chatale BC et al (2020) 3D-QSAR and pharmacophore modeling of 3,5-disubstituted Indole derivatives as Pim kinase inhibitors. Struct Chem 31:1675\u20131690. https:\/\/doi.org\/10.1007\/s11224-020-01503-1","journal-title":"Struct Chem"},{"key":"511_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cells6020015","volume":"6","author":"S Venkatesan","year":"2017","unstructured":"Venkatesan S, Khaw A, Hande M (2017) Telomere Biology\u2014Insights into an intriguing phenomenon. Cells 6:15. https:\/\/doi.org\/10.3390\/cells6020015","journal-title":"Cells"},{"key":"511_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00894-020-04648-2","volume":"27","author":"K Vishwakarma","year":"2021","unstructured":"Vishwakarma K, Bhatt H (2021) Molecular modelling of Quinoline derivatives as telomerase inhibitors through 3D-QSAR, molecular dynamics simulation, and molecular Docking techniques. J Mol Model 27:30. https:\/\/doi.org\/10.1007\/s00894-020-04648-2","journal-title":"J Mol Model"},{"key":"511_CR43","doi-asserted-by":"publisher","first-page":"115121","DOI":"10.1016\/j.ejmech.2023.115121","volume":"249","author":"K Vishwakarma","year":"2023","unstructured":"Vishwakarma K, Dey R, Bhatt H (2023) Telomerase: A prominent oncological target for development of chemotherapeutic agents. Eur J Med Chem 249:115121. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115121","journal-title":"Eur J Med Chem"},{"key":"511_CR44","doi-asserted-by":"publisher","unstructured":"Vora J, Patel S, Athar M et al (2019) Pharmacophore modeling, molecular Docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds. J Biomol Struct Dynamics 1\u201315. https:\/\/doi.org\/10.1080\/07391102.2019.1615002","DOI":"10.1080\/07391102.2019.1615002"},{"key":"511_CR45","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.snb.2016.08.021","volume":"239","author":"J Wang","year":"2017","unstructured":"Wang J, Liu L, Ma H (2017) Label-free real-time investigation of the effect of telomerase inhibitors based on quartz crystal microbalance measurement. Sens Actuators B 239:943\u2013950. https:\/\/doi.org\/10.1016\/j.snb.2016.08.021","journal-title":"Sens Actuators B"},{"key":"511_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejmech.2016.02.009","volume":"112","author":"Y Wang","year":"2016","unstructured":"Wang Y, Cheng FX, Yuan XL et al (2016) Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. Eur J Med Chem 112:231\u2013251. https:\/\/doi.org\/10.1016\/j.ejmech.2016.02.009","journal-title":"Eur J Med Chem"},{"key":"511_CR47","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1039\/c0cs00134a","volume":"40","author":"Y Xu","year":"2011","unstructured":"Xu Y (2011) Chemistry in human telomere biology: structure, function and targeting of telomere DNA\/RNA. Chem Soc Rev 40:2719. https:\/\/doi.org\/10.1039\/c0cs00134a","journal-title":"Chem Soc Rev"},{"key":"511_CR48","doi-asserted-by":"publisher","first-page":"e5184","DOI":"10.1002\/cpe.5184","volume":"31","author":"X Zhai","year":"2019","unstructured":"Zhai X, Amira A, Bensaali F et al (2019) Zynq SoC based acceleration of the lattice Boltzmann method. Concurrency Comput 31:e5184. https:\/\/doi.org\/10.1002\/cpe.5184","journal-title":"Concurrency Comput"},{"key":"511_CR49","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1109\/JSYST.2019.2952459","volume":"14","author":"X Zhai","year":"2020","unstructured":"Zhai X, Chen M, Esfahani SS et al (2020) Heterogeneous system-on-Chip-Based Lattice-Boltzmann visual simulation system. IEEE Syst J 14:1592\u20131601. https:\/\/doi.org\/10.1109\/JSYST.2019.2952459","journal-title":"IEEE Syst J"},{"key":"511_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bmc.2007.09.037","volume":"16","author":"L Zhang","year":"2008","unstructured":"Zhang L, Huang J, Ren L et al (2008) Synthesis and evaluation of cationic phthalocyanine derivatives as potential inhibitors of telomerase. Bioorg Med Chem 16:303\u2013312. https:\/\/doi.org\/10.1016\/j.bmc.2007.09.037","journal-title":"Bioorg Med Chem"},{"key":"511_CR51","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1016\/j.bmc.2012.08.059","volume":"20","author":"Y-B Zhang","year":"2012","unstructured":"Zhang Y-B, Wang X-L, Liu W et al (2012) Design, synthesis and biological evaluation of heterocyclic Azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. Bioorg Med Chem 20:6356\u20136365. https:\/\/doi.org\/10.1016\/j.bmc.2012.08.059","journal-title":"Bioorg Med Chem"},{"key":"511_CR52","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.1021\/jm050041b","volume":"48","author":"J-L Zhou","year":"2005","unstructured":"Zhou J-L, Lu Y-J, Ou T-M et al (2005) Synthesis and evaluation of Quindoline derivatives as G-Quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase. J Med Chem 48:7315\u20137321. https:\/\/doi.org\/10.1021\/jm050041b","journal-title":"J Med Chem"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-025-00511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-025-00511-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-025-00511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:44:39Z","timestamp":1742377479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-025-00511-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1007\/s13721-025-00511-7","relation":{},"ISSN":["2192-6670"],"issn-type":[{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent\/ethical approval"}},{"value":"This work was supported by the Major Research Project (NU\/Ph.D.\/Major_Res_Pro\/IP-NU\/21\u201322\/1115) funded by Nirma University, Ahmedabad, India and awarded to the authors HB, VV and BP. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial and competing interests disclosure"}}],"article-number":"18"}}